Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonsquamous Non Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01263782
What this trial is testing

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT04265534
What this trial is testing

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 40
Testing effectiveness (Phase 2)UnknownNCT03863483
What this trial is testing

Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy.

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 70
Testing effectiveness (Phase 2)Study completedNCT00798603
What this trial is testing

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Not applicableStudy completedNCT02420405
What this trial is testing

Mutation Detection of EBUS-TBNA Specimens Using NGS

Who this might be right for
Lung Cancer
Jiayuan Sun 78
Testing effectiveness (Phase 2)Study completedNCT01232452
What this trial is testing

A Study in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 172
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07806773
What this trial is testing

Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
NSCLCNon Small Cell Lung Cancer
Tubulis GmbH 80
Not applicableStudy completedNCT02416726
What this trial is testing

Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGS

Who this might be right for
Lung Cancer
Jiayuan Sun 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05403385
What this trial is testing

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerLocally Advanced NSCLC - Non-Small Cell Lung Cancer
iTeos Therapeutics 36
Large-scale testing (Phase 3)Study completedNCT00762034
What this trial is testing

Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 939
Testing effectiveness (Phase 2)Study completedNCT01473563
What this trial is testing

Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Nonsquamous Non-Small Cell Neoplasm of LungNon-Small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB
Eli Lilly and Company 52
Large-scale testing (Phase 3)Ended earlyNCT04786964
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

Who this might be right for
Metastatic Non-squamous Non Small Cell Lung Cancer
Checkpoint Therapeutics, Inc. 25
Large-scale testing (Phase 3)Study completedNCT01017874
What this trial is testing

Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 236
Large-scale testing (Phase 3)Study completedNCT04716933
What this trial is testing

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 201
Not applicableStudy completedNCT01814163
What this trial is testing

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Spanish Lung Cancer Group 200
Testing effectiveness (Phase 2)Study completedNCT01165021
What this trial is testing

Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 19
Large-scale testing (Phase 3)UnknownNCT01481259
What this trial is testing

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06012435
What this trial is testing

SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Seagen, a wholly owned subsidiary of Pfizer 762
Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Early research (Phase 1)Study completedNCT03380871
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNonsquamous Nonsmall Cell Neoplasm of Lung
BioNTech US Inc. 38
Next Page